These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23278576)

  • 1. Synaptic basal lamina-associated congenital myasthenic syndromes.
    Maselli RA; Arredondo J; Ferns MJ; Wollmann RL
    Ann N Y Acad Sci; 2012 Dec; 1275():36-48. PubMed ID: 23278576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental consequences of the ColQ/MuSK interactions.
    Karmouch J; Dobbertin A; Sigoillot S; Legay C
    Chem Biol Interact; 2013 Mar; 203(1):287-91. PubMed ID: 23089045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.
    Arredondo J; Lara M; Ng F; Gochez DA; Lee DC; Logia SP; Nguyen J; Maselli RA
    Hum Genet; 2014 May; 133(5):599-616. PubMed ID: 24281389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific binding of collagen Q to the neuromuscular junction is exploited to cure congenital myasthenia and to explore bases of myasthenia gravis.
    Ohno K; Ito M; Kawakami Y; Krejci E; Engel AG
    Chem Biol Interact; 2013 Mar; 203(1):335-40. PubMed ID: 22981737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
    Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
    Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular bases and therapeutic strategies in defective neuromuscular transmissions: lessons learned from a prototypical synapse].
    Ohno K; Ito M; Masuda A
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Aug; 29(4):145-51. PubMed ID: 19764481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional organization of synaptic acetylcholinesterase.
    Aldunate R; Casar JC; Brandan E; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):96-104. PubMed ID: 15572165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting acetylcholinesterase to the neuromuscular synapse.
    Rotundo RL; Rossi SG; Kimbell LM; Ruiz C; Marrero E
    Chem Biol Interact; 2005 Dec; 157-158():15-21. PubMed ID: 16289417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterases and the basal lamina at vertebrate neuromuscular junctions.
    Massoulié J; Millard CB
    Curr Opin Pharmacol; 2009 Jun; 9(3):316-25. PubMed ID: 19423392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-anchoring therapy to target extracellular matrix proteins to their physiological destinations.
    Ito M; Ohno K
    Matrix Biol; 2018 Aug; 68-69():628-636. PubMed ID: 29475025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MuSK is required for anchoring acetylcholinesterase at the neuromuscular junction.
    Cartaud A; Strochlic L; Guerra M; Blanchard B; Lambergeon M; Krejci E; Cartaud J; Legay C
    J Cell Biol; 2004 May; 165(4):505-15. PubMed ID: 15159418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms.
    Legay C
    Ann N Y Acad Sci; 2018 Feb; 1413(1):104-110. PubMed ID: 29405353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
    Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
    Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency.
    Ishigaki K; Nicolle D; Krejci E; Leroy JP; Koenig J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2003 Mar; 13(3):236-44. PubMed ID: 12609505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.
    McMacken GM; Spendiff S; Whittaker RG; O'Connor E; Howarth RM; Boczonadi V; Horvath R; Slater CR; Lochmüller H
    Hum Mol Genet; 2019 Jul; 28(14):2339-2351. PubMed ID: 31220253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.